Location: Webinar - Virtual
Start Date: Oct 08, 2024
Type of Event: Webinars

This webinar has since taken place and is now available to watch on-demand.

About the Webinar

As episode 5 in our webinar series, “Quality Hits at Lightning Speed”, this webinar discusses Cell Painting as a high content imaging method and one of Evotec's variety of phenotypic screening assays in drug discovery programs.

Dr. Karsten Kottig, VP Imaging & Analysis and Dr. Sven Schreiter,  Senior Research Scientist High-Throughput Screening, will share insights into Evotec's high content imaging capabilities, explain the basic concept of Cell Painting and its usage as a phenotypic platform across drug discovery phases.

Meet Our Speakers

Headshot of Karsten Kottig
Evotec logo big

Karsten Kottig

VP Imaging & Analysis

Evotec logo big

Latest update: July 2024

Biography 


• PhD in Biophysics from the Max Planck Institute for Biochemistry / TU Munich
• 2000: Joined Evotec Biosystems AG as project leader for software development of the miniaturized high through screening systems (EVOscreen).
• 2002 – 2006: Evotec Technologies GmbH as application manager for single molecule detection systems and scientific software development for image analysis (PicoScreen, Acapella)
• 2007 – 2012: PerkinElmer Cellular Technologies Germany GmbH as project leader for scientific software development for image data management and analysis (Columbus, Harmony)
• 2012 – now: Evotec SE as global leader for high content imaging and analysis.

Evotec logo big
Headshot of Sven Schreiter
Evotec logo big

Sven Schreiter

Senior Research Scientist High-Throughput Screening

Evotec logo big

Latest update: September 2024

Biography


>10 years of experience in academia and industry
Personal background: Molecular Biology, iPSC/Cell-based Assays, High Content Screening and Small Molecule High Throughput Screening

PhD in Biology from the Center for Regenerative Therapies Dresden / TU Dresden

2010 – 2011:
joined Max-Planck-Institute for Evolutionary Anthropology (Evolutionary Genetics group Svante Pääbo) as master student/research fellow
2012 – 2018:
joined Center for Regenerative Therapies Dresden for PhD (work group Elly Tanaka) and Postdoctoral work (Cleansight group).
2018 – now:
joined Evotec as scientist in the High Throughput Screening group

Evotec logo big

Watch On-Demand

More About the Series

Learn more about the series and watch the previous parts on demand here.